Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-059462
Filing Date
2019-12-06
Accepted
2019-12-06 16:05:11
Documents
2
Period of Report
2019-12-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1554
2 POA DOCUMENT poa.txt EX-24.3_882416 4335
  Complete submission text file 0001209191-19-059462.txt   7291
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address
Squarer Ron (Reporting) CIK: 0001454001 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38219 | Film No.: 191273146

Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Issuer) CIK: 0001654151 (see all company filings)

EIN.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations